Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US29479A1088
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00MTSR883
ERAS
Erasca Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Erasca Inc
ISIN
US29479A1088
TICKER
ERAS
MIC
XNAS
REUTERS
ERAS.OQ
BLOOMBERG
ERAS US
Mo., 13.07.2026       Erasca
US29479A1088

SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell, subject to market and other conditions, $500.0 mill...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 13.07.2026       Erasca
US29479A1088

At RDE of 32 mg QD, encouraging monotherapy responses with 57% uORR in 2L+ KRAS G12X pancreatic cancer in U.S. trial and median relative dose intensity of 100%...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 13.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 13.07.2026       Erasca
US29479A1088

LOS ANGELES, July 13, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Erasca, Inc. ("Erasca" or "the Company") (NASDAQ: ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who pu...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 13.07.2026       Erasca
US29479A1088

LOS ANGELES, July 13, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Erasca, Inc. ("Erasca" or "the Company") (NASDAQ: ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Secur...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 13.07.2026       Erasca
US29479A1088

NEW YORK, July 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plainti...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 11.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 11.07.2026       Erasca
US29479A1088

NEW ORLEANS, July 10, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against Erasca, Inc. (NasdaqGS: ERAS) ("Erasca" or the "Company"), if they purchased or otherwise acquired the Company's secu...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 10.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca c...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Fr., 10.07.2026       Erasca
US29479A1088

BENSALEM, Pa., July 10, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ERASCA, INC. (ERAS), CONTACT THE LAW OFFIC...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Fr., 10.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 10, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the f...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 09.07.2026       Erasca
US29479A1088

NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 09.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 09.07.2026       Erasca
US29479A1088

Institutional investors holding positions in Erasca, Inc. (NASDAQ: ERAS) during the period from January 14, 2025 through April 26, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (2...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 09.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 9, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 09.07.2026       Erasca
US29479A1088

SAN DIEGO, July 9, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, both dates inclusive (the "Class Period"), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the Erasc...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 09.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 8, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to rec...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 08.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca common...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 08.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the fe...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 08.07.2026       Erasca
US29479A1088

Critical Information: ERAS Investors Lost $11.59 Per Share as Artificially Inflated Stock Price Collapsed Following Dual Corrective Disclosures on April 27-28, 2026NEW YORK, July 8, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Erasca, Inc. (NASDAQ: ERAS) securities of a pending securities class action....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 08.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 7, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 08.07.2026       Erasca
US29479A1088

NEW YORK, July 7, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintif...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 07.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 07.07.2026       Erasca
US29479A1088

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 07.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to rec...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 07.07.2026       Erasca
US29479A1088

Philadelphia, Pennsylvania--(Newsfile Corp. - July 7, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") on behalf of investors who purchased or acquired Erasca common stock during the period from January 14, 2025 through April 26, 2026 (the "Clas...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 07.07.2026       Erasca
US29479A1088

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Erasca, Inc. ("Erasca" or "the Company") (NASDAQ: ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who pur...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 07.07.2026       Erasca
US29479A1088

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Erasca, Inc. ("Erasca" or "the Company") (NASDAQ: ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securi...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 06.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 6, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to rec...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mo., 06.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
So., 05.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 5, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the fe...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
So., 05.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca common...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
So., 05.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 04.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca co...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 04.07.2026       Erasca
US29479A1088

NEW YORK and NEW ORLEANS, July 3, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NasdaqGS: ERAS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks t...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Sa., 04.07.2026       Erasca
US29479A1088

If you have suffered a loss on your Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ:ERAS) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.Investors have until August 10, 202...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 02.07.2026       Erasca
US29479A1088

SAN DIEGO, July 2, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 02.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 2, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to rec...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 02.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintiff deadline.SO WHAT: If you purchased Erasca co...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 02.07.2026       Erasca
US29479A1088

SAN FRANCISCO, July 2, 2026 /PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month after receiving...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Do., 02.07.2026       Erasca
US29479A1088

NEW YORK, July 1, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Erasca, Inc. (NASDAQ: ERAS) between January 14, 2025 and April 26, 2026, inclusive (the "Class Period"), of the important August 10, 2026 lead plaintif...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 01.07.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 1, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to rec...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 01.07.2026       Erasca
US29479A1088

San Francisco, California--(Newsfile Corp. - July 1, 2026) -  Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 01.07.2026       Erasca
US29479A1088

New York, New York--(Newsfile Corp. - July 1, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Erasca, Inc. (NASDAQ: ERAS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of the fe...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 01.07.2026       Erasca
US29479A1088

Erasca's repeated preclinical comparisons to Revolution Medicines' RMC-6236 were allegedly improper and placed the company at risk of patent and trade secret violations, costing investors over $11 per share when the truth emerged.NEW YORK, July 1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Erasca, Inc. (NASDAQ: ERAS) that...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 01.07.2026       Erasca
US29479A1088

SAN DIEGO, July 1, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Erasca, Inc. (NASDAQ: ERAS) common stock between January 14, 2025 and April 26, 2026, both dates inclusive (the "Class Period"), have until Monday, August 10, 2026 to seek appointment as lead plaintiff of the Erasc...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Mi., 01.07.2026       Erasca
US29479A1088

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Erasca To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Erasca between January 14, 2025 and April 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 30.06.2026       Erasca
US29479A1088

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 30, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to re...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 30.06.2026       Erasca
US29479A1088

LOS ANGELES, June 30, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS)....
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink
Di., 30.06.2026       Erasca
US29479A1088

Philadelphia, Pennsylvania--(Newsfile Corp. - June 30, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) ("Erasca" or the "Company") on behalf of investors who purchased or acquired Erasca common stock during the period from January 14, 2025 through April 26, 2026 (the "Cla...
Zur Nachricht
Erasca
Charts & Research Termsheets Terminal
Permalink